Healthcare -
Biotechnology - NASDAQ - US
$ 1.1155
1.68 %
$ 33.7 M
Market Cap
-0.74
P/E
ANTX - OPERATING INCOME
Operating Income ANTX - AN2 Therapeutics, Inc.
-54.6 M
LAST VALUE
-13.62%
2 YEAR CAGR
-60.15%
5 YEAR CAGR
0.00%
10 YEAR CAGR